Analyst Reco. National Health Investors, Inc.

Stocks

NHI

US63633D1046

Specialized REITs

Market Closed - NYSE Other stock markets 21:00:02 12/06/2026 BST			5-day change	1st Jan Change
72.10 ^USD	+0.19%		+2.37%	-5.59%

06-12	Truist Lowers Price Target on National Health Investors to $81 From $89, Keeps Buy Rating	MT
05-05	National Health Investors, Inc., Q1 2026 Earnings Call, May 05, 2026

Analyst Reco.

06-12	Truist Lowers Price Target on National Health Investors to $81 From $89, Keeps Buy Rating	MT
04-22	Truist Lowers Price Target on National Health Investors to $89 From $92, Keeps Buy Rating	MT
03-12	Truist Raises Price Target on National Health Investors to $92 From $85, Keeps Buy Rating	MT
01-20	Deutsche Bank Downgrades National Health Investors to Hold From Buy, Adjusts Price Target to $85 From $90	MT
01-20	Truist Raises Price Target on National Health Investors to $85 From $83, Keeps Buy Rating	MT
12-15	Truist Adjusts Price Target on National Health Investors to $83 From $81, Maintains Buy Rating	MT
01/10/25	Cantor Fitzgerald Initiates Coverage on National Health Investors With Overweight Rating, $90 Price Target	MT
15/08/25	Truist Adjusts Price Target on National Health Investors to $81 From $77, Maintains Buy Rating	MT
10/07/25	KeyBanc Upgrades National Health Investors to Overweight From Sector Weight, Sets $80 Price Target	MT
02/07/25	National Health Investors Shares Rise After Upgrade From Truist	MT
02/07/25	Truist Upgrades National Health Investors to Buy From Hold, Maintains $77 Price Target	MT
09/06/25	Truist Raises Price Target on National Health Investors to $77 From $76, Keeps Hold Rating	MT
18/03/25	Truist Adjusts Price Target on National Health Investors to $76 From $70, Maintains Hold Rating	MT
17/01/25	Truist Cuts Price Target on National Health Investors to $70 From $72, Maintains Hold Rating	MT
02/01/25	Wedbush Cuts Price Target on National Health Investors to $77 From $87, Keeps Outperform Rating	MT
23/12/24	Truist Lowers Price Target on National Health Investors to $72 From $78, Keeps Hold Rating	MT
01/10/24	Wells Fargo Downgrades National Health Investors to Equal Weight From Overweight, Adjusts Price Target to $86 From $81	MT
24/09/24	BofA Securities Initiates Coverage on National Health Investors With Buy Rating	MT
30/08/24	Truist Securities Adjusts Price Target on National Health Investors to $78 From $65, Maintains Hold Rating	MT
27/08/24	Deutsche Bank Raises Price Target on National Health Investors to $90 From $69, Keeps Buy Rating	MT
26/06/24	Truist Securities Adjusts Price Target on National Health Investors to $65 From $58, Maintains Hold Rating	MT
18/03/24	Wedbush Raises National Health Investors' PT to $66 From $64 After Investor Meetings With Management, Maintains Outperform Rating	MT
12/03/24	BMO Capital Upgrades National Health Investors to Outperform From Market Perform	MT
26/02/24	Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Price Target is $63	MT
26/02/24	Wells Fargo Upgrades National Health Investors to Overweight From Equalweight, Adjusts Price Target to $63 From $55	MT